Children with pneumonia: How do they present and how are they managed?

Archives of Disease in Childhood

Volumn 92, Issue 5, 2007, Pages 394-398

  Clark, Julia E ^a   Hammal, Donna ^b   Spencer, David ^c   Hampton, Fiona ^d  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; CEFALEXIN; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G;

ARTICLE; BACTERIUM CULTURE; BREATHING RATE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; EMPYEMA; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; HYPOXIA; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG ADMINISTRATION SCHEDULE; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; OXYGEN; PLEURAL EFFUSION; PNEUMONIA, BACTERIAL; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; RESPIRATORY MECHANICS; SEVERITY OF ILLNESS INDEX;

EID: 34247882557     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.097402     Document Type: Article

References (30)

1. Henrickson KJ, Hoover S, Kehl KS, et al. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 2004;23(1 Suppl):S11-18.
2. Lynch T, Piatt R, Gouin S, et al. Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs? Pediatrics 2004;113(3 Pt 1):e186-9.
3. Langley JM, Bradley JS. Defining pneumonia in critically ill infants and children. Pediatr Crit Care Med 2005;6(3 Suppl):S9-13.
4. Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr (Phila) 2005;44(5):427-35.
5. Harari M, Shann F, Spooner V, et al. Clinical signs of pneumonia in children. Lancet 1991;338(8772):928-30.
6. Palafox M, Guiscafre H, Reyes H, et al. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000;82(1):41-5.
7. Cherian T, Simoes E, John TJ, et al. Evaluation of simple clinical signs for the diagnosis of acute lower respiratory tract infection. Lancet 1988;ii:125-8.
8. British Thoracic Society of Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in childhood. Thorax 2002;57:i1-24.
9. World Health Organization Pneumonia Vaccine Trial Investigators' Group. Standardization or interpretation of chest radiographs for the diagnosis of pneumonia in children. 2001. Available from http://www.who.int/ vaccine_research/ documents/en/pneumonia_children.pdf (accessed 20 February 2007).
10. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137(9):977-88.
11. Addo-Yobo E, Chisaka N, Hassan M, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 2004;364(9440):1141-8.
12. Atkinson M, Lorgelli P, Lakhanpaul M, et al. A randomised controlled equivalence trial to compare oral and intravenous treatment and the direct and indirect costs of treating children with community acquired pneumonia: PIVOT Trial [abstract]. Arch Dis Child 2005;90(Suppl 2):A87.
13. Payne SM, Donahue C, Rappo P, et al. Variations in pediatric pneumonia and bronchitis/asthma admission rates. Is appropriateness a factor? Arch Pediatr Adolesc Med 1995;149(2):162-9.
14. Lodha R, Bhadauria PS, Kuttikat AV, et al. Can clinical symptoms or signs accurately predict hypoxemia in children with acute lower respiratory tract infections? Indian Pediatr 2004;41(2):129-35.
15. Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1998;18(1):31-40.
16. Jadavji T, Law B, Lebel MH, et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ 1997;156(5):S703-11.
17. Rothrock SG, Green SM, Fanelli J-M, et al. Do published guidelines predict pneumonia in children presenting to an urban ED? Pediatr Emerg Care 2001;17(4):240-3.
18. Swingler GH. Radiologic differentiation between bacterial and viral lower respiratory infection in children: a systematic literature review. Clin Pediatr (Phila) 2000;39(11):627-33.
19. Peltola HMJ, Jaakkola M. Serious bacterial infections. C-reactive protein as a serial index of severity. Clin Pediatr (Phila) 1988;11:532-7.
20. Toikka PM, Irjala KM, Juven TM, et al. Diagnosis and management of pneumonia in children. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19(9):924-8.
21. Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997;10(5):1125-9.
22. Black SBM, Shinefield HRM, Ling SMM, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21(9):810-15.
23. Esposito S, Blasi F, Allegra L, et al. Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children. Eur J Clin Microbiol Infect Dis 2001;20(9):647-50.
24. Clements H, Stephenson T, Gabriel V, et al. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child 2000;83(4):320-4.
25. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004;59(6):522-5.
26. BNF for children, 1st edn. London: BMJ Publishing Group, 2005.
27. Quintiliani R. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials. Clin Ther 1996;18(3):372-90.
28. Jacobs MR, Dagan R. Antimicrobial resistance among pediatric respiratory tract infections: clinical challenges. Semin Pediatr Infect Dis 2004;15(1):5-20.
29. Lonks JR. What is the clinical impact of macrolide resistance? Curr Infect Dis Rep 2004;6(1):7-12.
30. Nuermberger E, Bishai WR. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clin Infect Dis 2004;38(1):99-103.